Fig. 6

Immune infiltration analyses and immunotherapeutic analyses. A The TME scores contrasting low and high-risk patients. B Boxplots of the infiltration levels of 22 specific immune cells. C Heatmap visually differentiating the quantities of 28 immune cells between high- and low-risk groups. D The relationships between risk scores and the infiltration of immune cells. E Differential expression of HLA-related genes. F Landscape of immune function differences. G The correlation between risk score and immune checkpoints, assessed using the Pearson test, where a significance of P < 0.001 was recorded. H The Kaplan–Meier curve comparing OS between the two risk subgroups in IMvigor210 cohort. I Box plots examining the relationship between risk score and the effectiveness of immunotherapy